Business
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
SAN FRANCISCO, May 08, 2025--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS) today announced its intention to offer, subject to market and other conditions, $450 million aggregate principal amount of convertible senior notes due 2030 (the "notes") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Hims & Hers also expects to grant the initial pur
About this update from Hims & Hers Health, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2562,"height":408,"url":"https://media.zenfs.com/en/business-wire.com/bb51ce225bd9fc5a0f24c5cf3d7e7370"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/GYGuzS3Azhu9M0Sm5CohuQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE1MztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/bb51ce225bd9fc5a0f24c5cf3d7e7370","width":960,"height":153},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/yh3P8QuclP9zbrmwSiBynQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zODI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/bb51ce225bd9fc5a0f24c5cf3d7e7370","width":1200,"height":191}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Proceeds intended to support Hims & Hers’ global expansion through organic growth and strategic acquisitions, while also fueling deeper investment in AI, diagnostics, and personalized treatments to scale access and meet rising demand for high-quality, personalized care","length":273,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":273,"olType":false},{"type":"text","content":"SAN FRANCISCO, May 08, 2025--(BUSINESS WIRE)--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS) today announced its intention to offer, subject to market and other conditions, $450 million aggregate principal amount of convertible senior notes due 2030 (the "notes") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Hims & Hers also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $67.5 million aggregate principal amount of notes.","length":783,"tagName":"p"},{"type":"text","content":"Hims & Hers intends to use proceeds from the offering for general corporate purposes, including accelerating global expansion through both organic growth and strategic acquisitions. Hims & Hers has no definitive agreements for any material acquisitions at this time. The funds will also support the technology team, led by newly appointed...